WebNov 4, 2024 · Precision oncology company MyNeo has released a new version of its ImmunoEngine bioinformatics platform. The update incorporates two new machine-learning algorithms, NeoMS, a transformer-based predictor based on major histocompatibility complex (MHC) ligandomic data, and NeoIM, a random-forest classifier trained to classify … WebMay 25, 2024 · Issuer: CureVac / Key word(s): Alliance25.05.2024 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac Partners with myNEO to Identify Novel Antigen Targets for mRNA-Based Cancer Vaccine Development CureVac is broadening its foundation in oncology, leveraging recent progress with its second …
Neoantigen prediction - myNEO personalised platform
WebMay 25, 2024 · myNEO focuses on neoantigen-directed immuno-oncology. On May 3, the company inked a strategic partnership with Sweden’s Abera Bioscience on cancer … WebmyNEO 2,041 من المتابعين على LinkedIn. Unlock the potential of neoantigen immunotherapies with data-driven innovation myNEO leads in Personalised Medicine and genomic-informed drug discovery in the key therapeutic areas of oncology and immunology. The myNEO ImmunoEngine© is a sequencing-based computational neoepitope selection platform that … katherine robinson obituary
Vacatures : Clinical Research, Wittemoer - 14 april 2024
WebApr 7, 2024 · Within the collaboration, the Belgium-based companies will use their respective technologies —OncoDNA's whole-genome and whole-transcriptome sequencing capabilities, and myNEO's artificial intelligence and bioinformatics capabilities — to identify targetable neoantigens in individual cancer patients and design mRNA-based vaccines that instruct … WebOncology Oncologists diagnose and treat cancers of all types. They use diagnostic tools like biopsies, endoscopies, X-ray and other imaging, nuclear medicine, and blood tests. WebmyNEO leads in genomic-informed target discovery in the field of immuno-oncology. The ImmunoEngine© is a computational sequencing-based … layered tables in r